MENU

ON-GOING CLINICAL TRIALS

1. A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (AVENUE) 

Click here for details.

2. A Phase 2 Study of RO6867461 in Participants With Center-Involving Diabetic Macular Edema (CI-DME) (BOULEVARD)

Click here for details.

3. Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection (ONYX)

Click here for details.

4. A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy (EXPOSURE)

Click here for details.

 

Contact the Retina Center Trial Department for more information:

Mary Montano Niles
Phone: 505-823-4411
Email: mmniles@eyenm.com

Jennifer Nelson
Phone: 505-823-4411
Email: jjnelson@eyenm.com